States engage in shadowy deals as death penalty drugs dwindle
Prisons share drugs, use shady pharmacies, try untested mixtures
Prison guards meet in the desert to hand off chemicals for executions. A corrections boss loaded with cash travels to a pharmacy in another state to buy lethal sedatives. States across the country refuse to identify the drugs they use to put the condemned to death.
Oklahoma officials agonized in court papers Monday about a shortage of lethal drugs necessary for an execution Thursday. They said they are scrambling to find more. “This has been nothing short of a Herculean effort,” Assistant Attorney General Seth Branham said. “Sadly, this effort has (so far) been unsuccessful.”
This is the curious state of capital punishment in America.
Manufacturers are cutting off supplies of lethal injection drugs because of opposition to the death penalty, and prison officials are improvising to make up the deficit — sharing drugs, buying them from under-regulated pharmacies or using drug combinations never employed before in putting someone to death.
At the same time, a number of states have ended capital punishment altogether. Others are delaying executions until they have a better understanding of what chemicals work best. And the media report blow-by-blow details of prisoners gasping, snorting or crying out during improvised lethal injection, taking seemingly forever to die.
Legal challenges across this new capital punishment landscape are flooding courts, further complicating efforts by states that utilize the death penalty.
“I’ve done everything I can do to carry out the executions that have been ordered in my state, and if somebody has an idea of how we can do that, I’d like to hear it,” Arkansas Attorney General Dustin McDaniel says.
The state has 33 people on death row, no executions since 2005 and a death penalty sidelined last month by a state judge complaining that the Arkansas law for lethal injection isn’t clear about what drugs should be used.
“I don’t know where it will all end up,” an exasperated McDaniel says. “I know that in the near future, we will see more litigation. We will see fewer executions. We will see states scrambling to come up with alternative methods. And there will be a lot of finger-pointing.”
Capital punishment in the USA is in decline. The number of executions has decreased from 98 in 1999 to 39 last year; death sentences fell 75% from 315 in 1996 to 80 in 2013.
Pressures on the death penalty are myriad, say those who study it. Juries are less willing to dispense it and prosecutors less likely to seek it. More states are choosing to abandon it.
“There’s been quite a radical change,” says Richard Dieter, executive director of the non-profit Death Penalty Information Center, a clearinghouse for information and an opponent of executions.
Although a majority of Americans support capital punishment, according to Gallup surveys, that 60% is the lowest number since 1972. Three thousand people linger on death rows nationwide.
Further complicating the debate are cases in which an innocent person is sentenced to death. This month, a Louisiana court ordered the release of Glenn Ford, on death row for 30 years, after prosecutors concluded he had been wrongly convicted in a murder in 1983.
The biggest hurdle in recent years has been a practical one — in a nation in which the overwhelming method of execution is lethal injection, corrections officials are having difficulty getting their hands on the drugs they need.
The result is improvisation. The first four people put to death this year — one each in Florida, Oklahoma, Ohio and Texas — were killed four different ways with various drug combinations.
Ohio executed Dennis McGuire, who raped and murdered a pregnant woman in 1989, with a cocktail of the anti-seizure medicine midazolam and the opioid hydromorphone.
No state had ever tried this combination before. It took 26 minutes for McGuire to die. Media reports described him as snorting, arching his back, clenching his arms, hands and shoulders and apparently gasping for air.
His family complained that this was a case of cruel and unusual punishment. Three weeks later, Ohio Gov. John Kasich, a Republican, postponed the next scheduled execution for eight months while the state tries to figure out what happened in McGuire’s death.
Supporters of the death penalty say the dispute over lethal injection is purely political.
“There are anesthesiologists across the country rolling their eyes,” says Scott Burns, executive director of the National District Attorneys Association. “This isn’t about obtaining the drugs or cruel and unusual punishment. This is about those opposed to the death penalty coming up with yet another issue to try to halt, delay or continue the debate.”
DRUG FIRMS RELUCTANT
For many years, states uniformly relied on a “three-drug protocol” to execute prisoners, beginning with an anesthetic to render the condemned unconscious, then a muscle relaxant to keep them still and, finally, a chemical to stop the heart.
Five years ago, drugmakers and pharmacies that sell them — particularly those in Europe, where capital punishment is anathema — began cutting off production or were barred from exporting drugs for U.S. executions.
The sedative sodium thiopental, used for decades in lethal injections, no longer was available. The Danish-based manufacturer of a fallback drug, the fast-acting anesthetic pentobarbital, blocked its sale for capital punishment.
State correction officials were left begging and borrowing, some hoarding what they had and refusing to share.
California launched a “secret mission” to swap some of its muscle relaxant for vials of Arizona’s sodium thiopental in 2010. A team of California guards, picking up “the package” from Arizona, shuttled it north on Interstate 5, handing it off in the San Joaquin Valley to a second team that took it to San Quentin’s death row.
Scott Kernan, then a California prison official, exulted over the trip’s success in an e-mail that became grist for Comedy Central’s Colbert Report: “You guys in AZ are life savers. By (sic) you a beer next time I get that way.”
More recently, Missouri corrections officer Dave Dormire testified that he personally delivered $11,000 to a pharmacy he found in the Yellow Pages for testing and purchasing of pentobarbital. “I take them cash,” he told lawyers suing to block an execution in January.
DON’T LIKE PUBLICITY
State executioners increasingly turn to drug companies called compounding pharmacies because of their willingness to custom-mix drugs.
They were largely unregulated by the Food and Drug Administration until last fall, when Congress gave it more authority after a Massachusetts compounding pharmacy’s tainted drugs led to a meningitis outbreak in 2012 that killed 64 people.
A problem for executioners is that the pharmacies become squeamish after being linked publicly with capital punishment.
Woodlands Compounding Pharmacy in Houston cut off its supply of pentobarbital to Texas last October after being revealed as a supplier.
Texas, the most prolific death penalty state, modified its threedrug protocol in 2011 and switched to one drug in 2012, all because of shortages, corrections spokesman Jason Clark says. “A single, lethal dose of pentobarbital is now administered,” he says.
The Associated Press says the state will run out of that barbiturate by the end of this month, and three executions are slated for April. Clark says officials are looking for more drugs.
Oklahoma solves the problem of embarrassed pharmacies by buying drugs with cash, avoiding a paper trail. “It was one way we could expend cash and help hide the identify of people we are paying money to,” says Jerry Massie, a state corrections spokesman.
State legislators in New Hampshire and Missouri have suggested reinstating forms of execution such as electrocution or firing squad. McDaniel doubts the public would want to reverse a trend toward what many view as more humane methods.
“The euthanasia element of lethal injection has allowed the public to temper their desire for the ultimate justice with their delicate sensibilities,” he says.